More on Pfizer (PFE) Q2: net profit +25% to $3.25B despite a 9% fall in revenue following...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

More on Pfizer (PFE) Q2: net profit +25% to $3.25B despite a 9% fall in revenue following Lipitor's patent expiration, with the bottom line benefiting from major cost cuts. Pfizer plans to file to sell 20% of its animal health business, to be called Zoetis, in an IPO in mid-August. Shares +0.8% premarket.